Italia markets closed

BMY Sep 2024 46.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,2500+0,5400 (+31,58%)
In data: 03:49PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,7100
Aperto2,1500
Denaro2,2400
Lettera2,2800
Prezzo d'esercizio46,00
Scadenza2024-09-20
Min-Max giorno2,1200 - 2,2500
Contratto - Min-MaxN/D
Volume28
Open Interest537
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri